|4Sep 3, 9:41 PM ET

BAMFORD PASCAL 4

4 · Akoya Biosciences, Inc. · Filed Sep 3, 2024

Insider Transaction Report

Form 4
Period: 2024-08-29
BAMFORD PASCAL
Chief Clinical Officer
Transactions
  • Award

    Common Stock

    2024-08-29+40,000122,758 total
Footnotes (2)
  • [F1]The restricted stock units shall vest in full on the second anniversary of the first day of the month subsequent to the date of grant.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES